What Researchers Did
Researchers conducted a scoping review and meta-analysis to evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) for radiation-induced urologic injury.
What They Found
Among 602 patients receiving HBOT for hemorrhagic radiation cystitis (HRC), 84% experienced partial or complete resolution. Additionally, 75% of patients in seven studies showed at least one grade improvement in hematuria, but 14% of 499 patients had recurrence with a median time of 10 months.
What This Means for Canadian Patients
Hyperbaric oxygen therapy appears to be an effective treatment option for Canadian patients experiencing radiation-induced hemorrhagic cystitis, potentially resolving symptoms like hematuria. Patients should discuss this therapy with their healthcare providers to understand its benefits and the risk of recurrence.
Canadian Relevance
This study did not include any Canadian participants or data, so its direct Canadian relevance is not established.
Study Limitations
A key limitation is the scarcity of recent randomized controlled trials, with the only one performed in 2012, impacting the overall strength of evidence.